SARS-CoV-2 Gamma variant
Variant of the virus SARS-CoV-2
SARS-CoV-2 Gamma variant ▸ Facts ▸ Comments ▸ News ▸ Videos
The Gamma variant (P.1) was one of the variants of SARS-CoV-2, the virus that causes COVID-19. This variant of SARS-CoV-2 has been named lineage P.1 and has 17 amino acid substitutions, ten of which in its spike protein, including these three designated to be of particular concern: N501Y, E484K and K417T. This variant of SARS-CoV-2 was first detected by the National Institute of Infectious Diseases (NIID) of Japan, on 6 January 2021 in four people who had arrived in Tokyo having visited Amazonas, Brazil, four days earlier. It was subsequently declared to be in circulation in Brazil. Under the simplified naming scheme proposed by the World Health Organization, P.1 has been labeled Gamma variant, and is currently considered a variant of concern.
| 0 shares | ShareTweetSavePostSend |
You Might Like
Covishield, Covaxin work against SARS-CoV-2's Alpha, Beta, Gamma, Delta variants: GovernmentVaccines Covishield and Covaxin work against SARS-CoV-2 variants Alpha, Beta, Gamma and Delta, while effectiveness tests against the Delta Plus variant is ongoing, the government said on Friday.IndiaTimes - Published | |
US CDC classifies Delta variant as 'variant of concern'The US Centers for Disease Control and Prevention has classified the Delta, a highly transmissible Covid-19 variant first identified in India, as a "variant of concern." "The B.1.1.7 (Alpha), B.1.351..IndiaTimes - Published |
| Search this site and the web: |
